In November 2020, longstanding UMC director Marie Lindquist began her well-earned retirement, leaving the reins of the organisation to her successor Hervé Le Louët. As she prepared to open a new chapter in her life, she sat down with Uppsala Reports to take a fond look back at an extraordinary career: a 40-year-long path that began with a knock on the door and turned her into one of the world’s leading advocates for patient safety.

This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here.

Tune in to find out:

• Why monitoring the safety of medicines and vaccines matters more than ever during the COVID-19 pandemic
• How UMC’s methods and tools have advanced the science of pharmacovigilance 
• Why it’s important to see the patient behind the data

Want to know more?
Uppsala Monitoring Centre has been leading a global effort to improve the science of pharmacovigilance for more than 40 years.

You can read a comprehensive history of the organisation in the book Making Medicines Safer.

If you’d like free regular updates from the world of pharmacovigilance, subscribe to the monthly Uppsala Reports newsletter.

Join the conversation on social media
Follow us on Facebook, LinkedIn, X, or Bluesky and share your thoughts about the show with the hashtag #DrugSafetyMatters.

Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!

About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.